Key Features API-first headless architecture with complete frontend freedom (React, Next.js, Vue, any framework) Native subscription engine with flexible billing, automated retry, dunning, mixed carts, pause/resume Multi-gateway payment support: Stripe, Braintree, Authorize.net, PayPal, Saferpay, QuickPay, plus custom processor integrations Unlimited product variants and custom attributes with no cap on options or SKU combinations Custom data models for prescription fields, compliance metadata, and insurance information Visual store builder plus full headless option for omnichannel selling 230 currencies, 170 languages natively included Full-stack app platform with serverless functions, CLI tooling, and clean API documentation PCI DSS Level 1, GDPR, CCPA compliant Revenue-based fee structure above plan thresholds, competitive with other platforms' percentage-based transaction fees Best for: Semaglutide brands that need native subscriptions, multi-gateway payment flexibility, unlimited product variants, and an API-first architecture that scales from launch through enterprise growth without replatforming

Continue reading Tirzepatide vs semaglutide: How do they compare
2012) Exenatide has 53% homology with GLP-1
Are there other tri-agonist peptides in development besides Retatrutide